Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-06-28

FDA Approved: HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE — Supplemental Application (Lupin Pharmaceuticals,Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' supplemental application for Hydrocodone bitartrate and homatropine methylbromide, maintaining its approved use as an antitu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydrocodone Bitartrate and Homatropine Methylbromide (Hydrocodone Bitartrate and Homatropine Methylbromide)

Snippet

SUPPL AP for HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE (HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE)